Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Betaine resolves severe alcohol-induced hepatitis and steatosis following liver transplantation.

Literature DB >> 16944015

Betaine resolves severe alcohol-induced hepatitis and steatosis following liver transplantation.

Karim Samara¹, Chen Liu, Consuelo Soldevila-Pico, David R Nelson, Manal F Abdelmalek.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2006 PMID： 16944015 DOI： 10.1007/s10620-006-8038-3

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

20 in total

1. A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis.

Authors: M Basaranoglu; O Acbay; A Sonsuz
Journal: J Hepatol Date: 1999-08 Impact factor: 25.083

Review 2. Cytokines in alcoholic and nonalcoholic steatohepatitis.

Authors: H Tilg; A M Diehl
Journal: N Engl J Med Date: 2000-11-16 Impact factor: 91.245

Review 3. Timing of liver transplantation in alcoholic cirrhosis.

Authors: Santiago Tome; Michael R Lucey
Journal: J Hepatol Date: 2003-09 Impact factor: 25.083

4. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.

Authors: M F Abdelmalek; P Angulo; R A Jorgensen; P B Sylvestre; K D Lindor
Journal: Am J Gastroenterol Date: 2001-09 Impact factor: 10.864

5. Metformin in non-alcoholic steatohepatitis.

Authors: G Marchesini; M Brizi; G Bianchi; S Tomassetti; M Zoli; N Melchionda
Journal: Lancet Date: 2001-09-15 Impact factor: 79.321

6. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.

Authors: Gamze Ayata; Fredric D Gordon; W David Lewis; Elizabeth Pomfret; James J Pomposelli; Roger L Jenkins; Urmila Khettry
Journal: Hum Pathol Date: 2002-11 Impact factor: 3.466

7. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.

Authors: A Poonawala; S P Nair; P J Thuluvath
Journal: Hepatology Date: 2000-10 Impact factor: 17.425

Review 8. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

Authors: Ian R Wanless; Koji Shiota
Journal: Semin Liver Dis Date: 2004-02 Impact factor: 6.115

Betaine resolves severe alcohol-induced hepatitis and steatosis following liver transplantation.

1. A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis.

Review 2. Cytokines in alcoholic and nonalcoholic steatohepatitis.

Review 3. Timing of liver transplantation in alcoholic cirrhosis.

4. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.

5. Metformin in non-alcoholic steatohepatitis.

6. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.

7. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.

Review 8. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

9. Weight change and obesity after liver transplantation: incidence and risk factors.

10. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

1. Recent and currently emerging medical treatment options for the treatment of alcoholic hepatitis.

2. Betaine inhibits toll-like receptor 4 expression in rats with ethanol-induced liver injury.

Review 3. Hepatic inflammation and progressive liver fibrosis in chronic liver disease.

Review 4. Role of betaine in liver disease-worth revisiting or has the die been cast?

Review 5. Betaine in ameliorating alcohol-induced hepatic steatosis.

6. Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease.